Skip to content

study the Effect of Laghumalini Vasant in Pratham Patalgat Timir

Open randomized Control Clinical Trial of Laghumalini Vasant in Pratham Patalgat Timir with special reference to Simple Myopia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080099
Enrollment
84
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H53- Visual disturbances

Interventions

None listed

Sponsors

Dr Usha Ghorpade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having signs and symptoms of Pratham Patalgat Timir will be included 2.Patients will be included from age group from 7-25yrs 3.Patients irrespective of gender, socioeconomic status, religion, occupation, educational status, cast and marital status will be included 4.The patients having simple myopia 5. The patients having blurring of vision

Exclusion criteria

Exclusion criteria: 1. Patient having traumatic & inflammatory injuries to eye. 2. Patients having malignancy, hypertension, diabetes, viral infections & other major retinal diseases maculopathy 3. Patients having sign & symptoms of Dwitiya, Tritiy and Chaturth Patalgat Timir. 4. Patients having post operative Myopia. 5. Patients suffering from infectious diseases like tubercular infection 6.Patients having congenital myopia and pathological myopia

Design outcomes

Primary

MeasureTime frame
Laghumalini Vasant is effective in Pratham Patalgat TimirTimepoint: Once at night for 30 days

Secondary

MeasureTime frame
Both Lagumalini Vasant & Saptamrit Loha are eqaually effective in Pratham Patalgat TimirTimepoint: Once in night for 30 days

Countries

India

Contacts

Public ContactDr Sujata Kate

Hon Shri Annasaheb Ayurved Medial College Post Graduation And Research Center Ashta

drsujatakate@gmail.com9404701645

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026